Global Multiplexed Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published: November 2022

No. of Pages: 106

Price:

Single User License: US $ 5600

Corporate User License: US $ 11200

Report Description
Table of Contents

Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Multiplexed Diagnostics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Multiplexed Diagnostics market. Further, it explains the major drivers and regional dynamics of the global Multiplexed Diagnostics market and current trends within the industry.

Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Agilent Technologies
- Bio-Rad Laboratories
- BioMerieux
- F. Hoffmann-La Roche
- Illumina
- Luminex
- Hologic
- Thermo Fisher Scientific
- Siemens Healthineers
- Abbott Laboratories

Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Multiplexed Diagnostics Segment by Type
- Very High Density Multiplexed Assays (Above 10,000-plex)
- High Density Multiplexed Assays (500 Below plex Below 10,000)
- Medium Density Multiplexed Assays (plex Below 500)
- Low Density Multiplexed Assays (plex Below 5)
- Next Generation Sequencing Assays
Multiplexed Diagnostics Segment by Application
- Academic Research Institutes
- Hospital
- Pharmaceutical Companies
- Clinical Research Organizations
- Diagnostic Laboratories

Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Multiplexed Diagnostics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:
This report presents an overview of global market for Multiplexed Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Multiplexed Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Multiplexed Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Multiplexed Diagnostics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Multiplexed Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Multiplexed Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Agilent Technologies, Bio-Rad Laboratories, BioMerieux, F. Hoffmann-La Roche, Illumina, Luminex, Hologic, Thermo Fisher Scientific and Siemens Healthineers, etc.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Very High Density Multiplexed Assays (Above 10,000-plex)
1.2.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.2.4 Medium Density Multiplexed Assays (plex Below 500)
1.2.5 Low Density Multiplexed Assays (plex Below 5)
1.2.6 Next Generation Sequencing Assays
1.3 Market by Application
1.3.1 Global Multiplexed Diagnostics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Academic Research Institutes
1.3.3 Hospital
1.3.4 Pharmaceutical Companies
1.3.5 Clinical Research Organizations
1.3.6 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Multiplexed Diagnostics Market Size (2017-2028)
2.2 Multiplexed Diagnostics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Multiplexed Diagnostics Market Size by Region (2017-2022)
2.4 Global Multiplexed Diagnostics Market Size Forecast by Region (2023-2028)
2.5 Global Top Multiplexed Diagnostics Countries Ranking by Market Size
3 Multiplexed Diagnostics Competitive by Company
3.1 Global Multiplexed Diagnostics Revenue by Players
3.1.1 Global Multiplexed Diagnostics Revenue by Players (2017-2022)
3.1.2 Global Multiplexed Diagnostics Market Share by Players (2017-2022)
3.2 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Multiplexed Diagnostics Revenue
3.4 Global Multiplexed Diagnostics Market Concentration Ratio
3.4.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2021
3.5 Global Multiplexed Diagnostics Key Players Head office and Area Served
3.6 Key Players Multiplexed Diagnostics Product Solution and Service
3.7 Date of Enter into Multiplexed Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Multiplexed Diagnostics Breakdown Data by Type
4.1 Global Multiplexed Diagnostics Historic Revenue by Type (2017-2022)
4.2 Global Multiplexed Diagnostics Forecasted Revenue by Type (2023-2028)
5 Global Multiplexed Diagnostics Breakdown Data by Application
5.1 Global Multiplexed Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Multiplexed Diagnostics Revenue by Company (2020-2022)
6.2 North America Multiplexed Diagnostics Revenue by Type (2017-2028)
6.3 North America Multiplexed Diagnostics Revenue by Application (2017-2028)
6.4 North America Multiplexed Diagnostics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Multiplexed Diagnostics Revenue by Company (2020-2022)
7.2 Europe Multiplexed Diagnostics Revenue by Type (2017-2028)
7.3 Europe Multiplexed Diagnostics Revenue by Application (2017-2028)
7.4 Europe Multiplexed Diagnostics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Multiplexed Diagnostics Revenue by Company (2020-2022)
8.2 Asia Pacific Multiplexed Diagnostics Revenue by Type (2017-2028)
8.3 Asia Pacific Multiplexed Diagnostics Revenue by Application (2017-2028)
8.4 Asia Pacific Multiplexed Diagnostics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Multiplexed Diagnostics Revenue by Company (2020-2022)
9.2 Latin America Multiplexed Diagnostics Revenue by Type (2017-2028)
9.3 Latin America Multiplexed Diagnostics Revenue by Application (2017-2028)
9.4 Latin America Multiplexed Diagnostics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Multiplexed Diagnostics Revenue by Company (2020-2022)
10.2 Middle East and Africa Multiplexed Diagnostics Revenue by Type (2017-2028)
10.3 Middle East and Africa Multiplexed Diagnostics Revenue by Application (2017-2028)
10.4 Middle East and Africa Multiplexed Diagnostics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Multiplexed Diagnostics Products and Services
11.1.4 Agilent Technologies Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.1.5 Agilent Technologies Multiplexed Diagnostics SWOT Analysis
11.1.6 Agilent Technologies Recent Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Multiplexed Diagnostics Products and Services
11.2.4 Bio-Rad Laboratories Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.2.5 Bio-Rad Laboratories Multiplexed Diagnostics SWOT Analysis
11.2.6 Bio-Rad Laboratories Recent Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Multiplexed Diagnostics Products and Services
11.3.4 BioMerieux Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.3.5 BioMerieux Multiplexed Diagnostics SWOT Analysis
11.3.6 BioMerieux Recent Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Multiplexed Diagnostics Products and Services
11.4.4 F. Hoffmann-La Roche Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.4.5 F. Hoffmann-La Roche Multiplexed Diagnostics SWOT Analysis
11.4.6 F. Hoffmann-La Roche Recent Developments
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Multiplexed Diagnostics Products and Services
11.5.4 Illumina Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.5.5 Illumina Multiplexed Diagnostics SWOT Analysis
11.5.6 Illumina Recent Developments
11.6 Luminex
11.6.1 Luminex Company Details
11.6.2 Luminex Business Overview
11.6.3 Luminex Multiplexed Diagnostics Products and Services
11.6.4 Luminex Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.6.5 Luminex Multiplexed Diagnostics SWOT Analysis
11.6.6 Luminex Recent Developments
11.7 Hologic
11.7.1 Hologic Company Details
11.7.2 Hologic Business Overview
11.7.3 Hologic Multiplexed Diagnostics Products and Services
11.7.4 Hologic Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.7.5 Hologic Multiplexed Diagnostics SWOT Analysis
11.7.6 Hologic Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Multiplexed Diagnostics Products and Services
11.8.4 Thermo Fisher Scientific Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.8.5 Thermo Fisher Scientific Multiplexed Diagnostics SWOT Analysis
11.8.6 Thermo Fisher Scientific Recent Developments
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Details
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Multiplexed Diagnostics Products and Services
11.9.4 Siemens Healthineers Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.9.5 Siemens Healthineers Multiplexed Diagnostics SWOT Analysis
11.9.6 Siemens Healthineers Recent Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Multiplexed Diagnostics Products and Services
11.10.4 Abbott Laboratories Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022)
11.10.5 Abbott Laboratories Multiplexed Diagnostics SWOT Analysis
11.10.6 Abbott Laboratories Recent Developments
12 Multiplexed Diagnostics Market Dynamics
12.1 Multiplexed Diagnostics Market Trends
12.2 Multiplexed Diagnostics Market Drivers
12.3 Multiplexed Diagnostics Market Challenges
12.4 Multiplexed Diagnostics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Tables
Table 1. Global Multiplexed Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Very High Density Multiplexed Assays (Above 10,000-plex)
Table 3. Key Players of High Density Multiplexed Assays (500 Below plex Below 10,000)
Table 4. Key Players of Medium Density Multiplexed Assays (plex Below 500)
Table 5. Key Players of Low Density Multiplexed Assays (plex Below 5)
Table 6. Key Players of Next Generation Sequencing Assays
Table 7. Global Multiplexed Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Multiplexed Diagnostics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Multiplexed Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Multiplexed Diagnostics Revenue Market Share by Region (2017-2022)
Table 11. Global Multiplexed Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Multiplexed Diagnostics Market Share by Players (2017-2022)
Table 13. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplexed Diagnostics as of 2021)
Table 14. Ranking of Global Top Multiplexed Diagnostics Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Multiplexed Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Multiplexed Diagnostics Product Solution and Service
Table 18. Date of Key Manufacturers Enter into Multiplexed Diagnostics Market
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Multiplexed Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 21. Global Multiplexed Diagnostics Revenue Market Share by Type (2017-2022)
Table 22. Global Multiplexed Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 23. Global Multiplexed Diagnostics Revenue Market Share by Type (2023-2028)
Table 24. Global Multiplexed Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 25. Global Multiplexed Diagnostics Revenue Market Share by Application (2017-2022)
Table 26. Global Multiplexed Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 27. Global Multiplexed Diagnostics Revenue Market Share by Application (2023-2028)
Table 28. North America Multiplexed Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 29. North America Multiplexed Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 30. North America Multiplexed Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 31. North America Multiplexed Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 32. North America Multiplexed Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 33. North America Multiplexed Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 34. North America Multiplexed Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 35. Europe Multiplexed Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 36. Europe Multiplexed Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 37. Europe Multiplexed Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 38. Europe Multiplexed Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 39. Europe Multiplexed Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 40. Europe Multiplexed Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 41. Europe Multiplexed Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 42. Asia Pacific Multiplexed Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 43. Asia Pacific Multiplexed Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Multiplexed Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Multiplexed Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Multiplexed Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Multiplexed Diagnostics Revenue by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Multiplexed Diagnostics Revenue by Region (2023-2028) & (US$ Million)
Table 49. Latin America Multiplexed Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 50. Latin America Multiplexed Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 51. Latin America Multiplexed Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 52. Latin America Multiplexed Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 53. Latin America Multiplexed Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 54. Latin America Multiplexed Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 55. Latin America Multiplexed Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Multiplexed Diagnostics Revenue by Company (2020-2022) & (US$ Million)
Table 57. Middle East and Africa Multiplexed Diagnostics Revenue by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Multiplexed Diagnostics Revenue by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Multiplexed Diagnostics Revenue by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Multiplexed Diagnostics Revenue by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Multiplexed Diagnostics Revenue by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Multiplexed Diagnostics Revenue by Country (2023-2028) & (US$ Million)
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies Multiplexed Diagnostics Product and Services
Table 66. Agilent Technologies Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 67. Agilent Technologies Multiplexed Diagnostics SWOT Analysis
Table 68. Agilent Technologies Recent Developments
Table 69. Bio-Rad Laboratories Company Details
Table 70. Bio-Rad Laboratories Business Overview
Table 71. Bio-Rad Laboratories Multiplexed Diagnostics Product and Services
Table 72. Bio-Rad Laboratories Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 73. Bio-Rad Laboratories Multiplexed Diagnostics SWOT Analysis
Table 74. Bio-Rad Laboratories Recent Developments
Table 75. BioMerieux Company Details
Table 76. BioMerieux Business Overview
Table 77. BioMerieux Multiplexed Diagnostics Product and Services
Table 78. BioMerieux Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 79. BioMerieux Multiplexed Diagnostics SWOT Analysis
Table 80. BioMerieux Recent Developments
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Multiplexed Diagnostics Product and Services
Table 84. F. Hoffmann-La Roche Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 85. F. Hoffmann-La Roche Multiplexed Diagnostics SWOT Analysis
Table 86. F. Hoffmann-La Roche Recent Developments
Table 87. Illumina Company Details
Table 88. Illumina Business Overview
Table 89. Illumina Multiplexed Diagnostics Product and Services
Table 90. Illumina Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 91. Illumina Multiplexed Diagnostics SWOT Analysis
Table 92. Illumina Recent Developments
Table 93. Luminex Company Details
Table 94. Luminex Business Overview
Table 95. Luminex Multiplexed Diagnostics Product and Services
Table 96. Luminex Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 97. Luminex Multiplexed Diagnostics SWOT Analysis
Table 98. Luminex Recent Developments
Table 99. Hologic Company Details
Table 100. Hologic Business Overview
Table 101. Hologic Multiplexed Diagnostics Product and Services
Table 102. Hologic Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 103. Hologic Multiplexed Diagnostics SWOT Analysis
Table 104. Hologic Recent Developments
Table 105. Thermo Fisher Scientific Company Details
Table 106. Thermo Fisher Scientific Business Overview
Table 107. Thermo Fisher Scientific Multiplexed Diagnostics Product and Services
Table 108. Thermo Fisher Scientific Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 109. Thermo Fisher Scientific Multiplexed Diagnostics SWOT Analysis
Table 110. Thermo Fisher Scientific Recent Developments
Table 111. Siemens Healthineers Company Details
Table 112. Siemens Healthineers Business Overview
Table 113. Siemens Healthineers Multiplexed Diagnostics Product and Services
Table 114. Siemens Healthineers Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 115. Siemens Healthineers Multiplexed Diagnostics SWOT Analysis
Table 116. Siemens Healthineers Recent Developments
Table 117. Abbott Laboratories Company Details
Table 118. Abbott Laboratories Business Overview
Table 119. Abbott Laboratories Multiplexed Diagnostics Product and Services
Table 120. Abbott Laboratories Multiplexed Diagnostics Revenue in Multiplexed Diagnostics Business (2017-2022) & (US$ Million)
Table 121. Abbott Laboratories Multiplexed Diagnostics SWOT Analysis
Table 122. Abbott Laboratories Recent Developments
Table 123. Multiplexed Diagnostics Market Trends
Table 124. Multiplexed Diagnostics Market Drivers
Table 125. Multiplexed Diagnostics Market Challenges
Table 126. Multiplexed Diagnostics Market Restraints
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiplexed Diagnostics Sales Market Share by Type: 2021 VS 2028
Figure 2. Very High Density Multiplexed Assays (Above 10,000-plex) Features
Figure 3. High Density Multiplexed Assays (500 Below plex Below 10,000) Features
Figure 4. Medium Density Multiplexed Assays (plex Below 500) Features
Figure 5. Low Density Multiplexed Assays (plex Below 5) Features
Figure 6. Next Generation Sequencing Assays Features
Figure 7. Global Multiplexed Diagnostics Sales Market Share by Application: 2021 VS 2028
Figure 8. Academic Research Institutes Case Studies
Figure 9. Hospital Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Clinical Research Organizations Case Studies
Figure 12. Diagnostic Laboratories Case Studies
Figure 13. Multiplexed Diagnostics Report Years Considered
Figure 14. Global Multiplexed Diagnostics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Multiplexed Diagnostics Market Size 2017-2028 (US$ Million)
Figure 16. Global Multiplexed Diagnostics Market Size Market Share by Region: 2021 VS 2028
Figure 17. Global Multiplexed Diagnostics Revenue Market Share by Region in 2017 VS 2022
Figure 18. Global Top 10 Multiplexed Diagnostics Countries Ranking by Market Size (US$ Million) in 2021
Figure 19. Global Multiplexed Diagnostics Market Share by Players in 2021
Figure 20. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplexed Diagnostics as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Multiplexed Diagnostics Revenue in 2021
Figure 22. North America Multiplexed Diagnostics Revenue Market Share by Company in 2021
Figure 23. North America Multiplexed Diagnostics Revenue Market Share by Type (2017-2028)
Figure 24. North America Multiplexed Diagnostics Revenue Market Share by Application (2017-2028)
Figure 25. North America Multiplexed Diagnostics Revenue Share by Country (2017-2028)
Figure 26. U.S. Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 27. Canada Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 28. Europe Multiplexed Diagnostics Revenue Market Share by Company in 2021
Figure 29. Europe Multiplexed Diagnostics Revenue Market Share by Type (2017-2028)
Figure 30. Europe Multiplexed Diagnostics Revenue Market Share by Application (2017-2028)
Figure 31. Europe Multiplexed Diagnostics Revenue Share by Country (2017-2028)
Figure 32. Germany Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 33. France Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 34. U.K. Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 35. Italy Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 36. Russia Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Multiplexed Diagnostics Revenue Market Share by Company in 2021
Figure 38. Asia Pacific Multiplexed Diagnostics Revenue Market Share by Type (2017-2028)
Figure 39. Asia Pacific Multiplexed Diagnostics Revenue Market Share by Application (2017-2028)
Figure 40. Asia Pacific Multiplexed Diagnostics Revenue Share by Region (2017-2028)
Figure 41. China Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 42. Japan Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 43. South Korea Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 44. India Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 45. Australia Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 46. Taiwan Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 47. Indonesia Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 48. Thailand Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 49. Malaysia Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 50. Philippines Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 51. Vietnam Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 52. Latin America Multiplexed Diagnostics Revenue Market Share by Company in 2021
Figure 53. Latin America Multiplexed Diagnostics Revenue Market Share by Type (2017-2028)
Figure 54. Latin America Multiplexed Diagnostics Revenue Market Share by Application (2017-2028)
Figure 55. Latin America Multiplexed Diagnostics Revenue Share by Country (2017-2028)
Figure 56. Mexico Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 57. Brazil Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 58. Argentina Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 59. Middle East and Africa Multiplexed Diagnostics Revenue Market Share by Company in 2021
Figure 60. Middle East and Africa Multiplexed Diagnostics Revenue Market Share by Type (2017-2028)
Figure 61. Middle East and Africa Multiplexed Diagnostics Revenue Market Share by Application (2017-2028)
Figure 62. Middle East and Africa Multiplexed Diagnostics Revenue Share by Country (2017-2028)
Figure 63. Turkey Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 64. Saudi Arabia Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 65. U.A.E Multiplexed Diagnostics Revenue (2017-2028) & (US$ Million)
Figure 66. Agilent Technologies Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 67. Bio-Rad Laboratories Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 68. BioMerieux Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 69. F. Hoffmann-La Roche Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 70. Illumina Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 71. Luminex Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 72. Hologic Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 73. Thermo Fisher Scientific Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 74. Siemens Healthineers Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 75. Abbott Laboratories Revenue Growth Rate in Multiplexed Diagnostics Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group2076975

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *